Sökning: WFRF:(Kronbichler Andreas) >
COVID-19 outcomes i...
-
Gauckler, PhilippMed Univ Innsbruck, Austria
(författare)
COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases
- Artikel/kapitelEngelska2023
Förlag, utgivningsår, omfång ...
-
FRONTIERS MEDIA SA,2023
-
electronicrdacarrier
Nummerbeteckningar
-
LIBRIS-ID:oai:DiVA.org:liu-198507
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-198507URI
-
https://doi.org/10.3389/fimmu.2023.1228457DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:153784673URI
Kompletterande språkuppgifter
-
Språk:engelska
-
Sammanfattning på:engelska
Ingår i deldatabas
Klassifikation
-
Ämneskategori:ref swepub-contenttype
-
Ämneskategori:art swepub-publicationtype
Anmärkningar
-
Funding Agencies|The authors thank Lalit Kaltenbach for his support with the creation and administration of the REDCap database.
-
Introduction: Patients with immune-mediated glomerular diseases are considered at high risk for severe COVID-19 outcomes. However, conclusive evidence for this patient population is scarce.Methods: We created a global registry and retrospectively collected clinical data of patients with COVID-19 and a previously diagnosed immune-mediated glomerular disease to characterize specific risk factors for severe COVID-19 outcomes.Results: Fifty-nine patients with a history of immune-mediated glomerular diseases were diagnosed with COVID-19 between 01.03.2020 and 31.08.2021. Over a mean follow-up period of 24.79 +/- 18.89 days, ten patients (16.9%) developed acute kidney injury. Overall, 44.1% of patients were managed in an outpatient setting and therefore considered as having "non-severe" COVID-19, while 55.9% of patients had severe COVID-19 requiring hospitalization including worse outcomes. Comparing both groups, patients with severe COVID-19 were significantly older (53.55 +/- 17.91 versus 39.77 +/- 14.95 years, p = .003), had lower serum albumin levels at presentation (3.00 +/- 0.80 g/dL versus 3.99 +/- 0.68 g/dL, p = .016) and had a higher risk of developing acute kidney injury (27% versus 4%, p = .018). Male sex (p <.001) and ongoing intake of corticosteroids at presentation (p = .047) were also significantly associated with severe COVID-19 outcomes, while the overall use of ongoing immunosuppressive agents and glomerular disease remission status showed no significant association with the severity of COVID-19 (p = .430 and p = .326, respectively).Conclusion: Older age, male sex, ongoing intake of corticosteroids and lower serum albumin levels at presentation were identified as risk factors for severe COVID-19 outcomes in patients with a history of various immune-mediated glomerular diseases.
Ämnesord och genrebeteckningar
Biuppslag (personer, institutioner, konferenser, titlar ...)
-
Kesenheimer, Jana S.Univ Innsbruck, Austria
(författare)
-
Geetha, DuvuruJohns Hopkins Univ, MD USA
(författare)
-
Odler, BalazsUniv Cambridge, England; Med Univ Graz, Austria
(författare)
-
Eller, KathrinMed Univ Graz, Austria
(författare)
-
Laboux, TimotheeUniv Lille, France; Univ Lille, France
(författare)
-
Alberici, FedericoUniv Brescia, Italy; Azienda Socio Sanit Territoriale ASST Spedali Civi, Italy
(författare)
-
Zappa, MattiaUniv Brescia, Italy; Azienda Socio Sanit Territoriale ASST Spedali Civi, Italy
(författare)
-
Chebotareva, NatashaSechenov First Moscow State Med Univ, Russia
(författare)
-
Moiseev, SergeySechenov First Moscow State Med Univ, Russia
(författare)
-
Bonilla, MarcoNorthwell Hlth, NY USA
(författare)
-
Jhaveri, Kenar D.Northwell Hlth, NY USA
(författare)
-
Oniszczuk, JulieParis East Univ, France
(författare)
-
Audard, VincentParis East Univ, France
(författare)
-
Costa, DeniseUniv Fed Pernambuco, Brazil
(författare)
-
Mastroianni-Kirsztajn, GiannaUniv Fed Sao Paulo, Brazil
(författare)
-
Bruchfeld, AnnetteKarolinska Institutet,Linköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Njurmedicinska kliniken US,Karolinska Inst, Sweden(Swepub:liu)anbru14
(författare)
-
Muto, MasahiroJuntendo Univ, Japan
(författare)
-
Windpessl, MartinKlinikum Wels Grieskirchen, Austria
(författare)
-
Mayer, GertMed Univ Innsbruck, Austria
(författare)
-
Kronbichler, AndreasMed Univ Innsbruck, Austria; Univ Cambridge, England
(författare)
-
Med Univ Innsbruck, AustriaUniv Innsbruck, Austria
(creator_code:org_t)
Sammanhörande titlar
-
Ingår i:Frontiers in Immunology: FRONTIERS MEDIA SA141664-3224
Internetlänk
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Gauckler, Philip ...
-
Kesenheimer, Jan ...
-
Geetha, Duvuru
-
Odler, Balazs
-
Eller, Kathrin
-
Laboux, Timothee
-
visa fler...
-
Alberici, Federi ...
-
Zappa, Mattia
-
Chebotareva, Nat ...
-
Moiseev, Sergey
-
Bonilla, Marco
-
Jhaveri, Kenar D ...
-
Oniszczuk, Julie
-
Audard, Vincent
-
Costa, Denise
-
Mastroianni-Kirs ...
-
Bruchfeld, Annet ...
-
Muto, Masahiro
-
Windpessl, Marti ...
-
Mayer, Gert
-
Kronbichler, And ...
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Medicinska och f ...
-
och Mikrobiologi ino ...
- Artiklar i publikationen
-
Frontiers in Imm ...
- Av lärosätet
-
Linköpings universitet
-
Karolinska Institutet